Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Endocytosis And Intracellular Trafficking As Gateways For Nanomedicine Delivery: Opportunities And Challenges.
R. Duncan, S. Richardson
Published 2012 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
More than 40 nanomedicines are already in routine clinical use with a growing number following in preclinical and clinical development. The therapeutic objectives are often enhanced disease-specific targeting (with simultaneously reduced access to sites of toxicity) and, especially in the case of macromolecular biotech drugs, improving access to intracellular pharmacological target receptors. Successful navigation of the endocytic pathways is usually a prerequisite to achieve these goals. Thus a comprehensive understanding of endocytosis and intracellular trafficking pathways in both the target and bystander normal cell type(s) is essential to enable optimal nanomedicine design. It is becoming evident that endocytic pathways can become disregulated in disease and this, together with the potential changes induced during exposure to the nanocarrier itself, has the potential to significantly impact nanomedicine performance in terms of safety and efficacy. Here we overview the endomembrane trafficking pathways, discuss the methods used to determine and quantitate the intracellular fate of nanomedicines, and review the current status of lysosomotropic and endosomotropic delivery. Based on the lessons learned during more than 3 decades of clinical development, the need to use endocytosis-relevant clinical biomarkers to better select those patients most likely to benefit from nanomedicine therapy is also discussed.
This paper references
Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells.
I. Alves (2010)
The dynamic nature of autophagy in cancer.
A. Kimmelman (2011)
Effect of molecular size of 125I-labelled poly(vinylpyrrolidone) on its pinocytosis by rat visceral yolk sacs and rat peritoneal macrophages.
R. Duncan (1981)
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides
L. Fei (2011)
Targeting of daunorubicin by association with DNA or proteins: a review.
A. Trouet (1984)
Welcome to Silence
D. Baulcombe (2010)
Characterising the size and shape of polyamidoamines in solution as a function of pH using neutron scattering and pulsed-gradient spin-echo NMR.
Z. Khayat (2006)
Nanocapsules: A new type of lysosomotropic carrier
P. Couvreur (1977)
Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.
H. Maeda (2010)
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
S. Libutti (2010)
Transfection of cells in culture with in vitro-derived rotavirus transcripts
Complementary methods to assist subcellular fractionation in organellar proteomics
D. J. Gauthier (2008)
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture.
J. Hänsler (1993)
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
K. Maier-Hauff (2010)
New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.
S. Muro (2010)
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
P. Felgner (1987)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
I-Labelled Poly(vinylpyrrolidone) on its Pinocytosis by Rat Visceral Yolk Sacs and Rat Peritoneal Macrophages, Biochemistry J.1980
J. Rejman (2004)
Syntaxin 6: The Promiscuous Behaviour of a SNARE Protein
F. Wendler (2001)
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
D. Scheinberg (2010)
Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.
L. Ducry (2010)
Polyvinylpyrrolidone storage disease presenting as pathologic fracture and anemia: Report of a case with imprint cytology
Wen-Chih Huang (2012)
Stability of antisense oligonucleotides during incubation with a mixture of isolated lysosomal enzymes
A. Hudson (1996)
Uptake and intracellular fate of polyethylenimine in vivo.
M. Lecocq (2000)
Large-scale profiling of Rab GTPase trafficking networks: the membrome.
Cemal Gurkan (2005)
Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease.
Janet Hsu (2011)
Membrane economics in endocytic systems.
R. Duncan (1977)
Designing polymer conjugates as lysosomotropic nanomedicines.
R. Duncan (2007)
Intracellular uptake, transport, and processing of gold nanostructures
D. Chithrani (2010)
Intracellular fate of bioresponsive poly(amidoamine)s in vitro and in vivo.
S. Richardson (2010)
Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex*
Ilana Berlin (2010)
Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
R. Duncan (2009)
Challenges for nanoparticle characterization.
S. Mcneil (2011)
Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells.
J. Zaro (2009)
Treating metastatic cancer with nanotechnology
Avi Schroeder (2011)
Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type.
K. Kostarelos (2007)
Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.
A. Cervantes (2011)
The cellular pathology of lysosomal diseases
T. Cox (2012)
Oligonucleotides During Incubation with a Mixture of Lysosomal Enzymes
M. Ogris (1996)
Tracking Intracellular Polymer Localization Via Fluorescence Microscopy
S. Richardson (2010)
Derailed endocytosis: an emerging feature of cancer
Yaron Mosesson (2008)
Effects of methylcyclodextrin on lysosomes.
M. Jadot (2001)
Decoupling Internalization, Acidification and Phagosomal-Endosomal/lysosomal Fusion during Phagocytosis of InlA Coated Beads in Epithelial Cells
C. Blanchette (2009)
Fate of micelles and quantum dots in cells.
D. Maysinger (2007)
H. Ewers (2011)
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
I. Hafez (2001)
Mechanism of polycation stimulation of pinocytosis.
R. Duncan (1979)
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
O. Boussif (1995)
First-in-human phase I study of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3) in patients with advanced solid tumors.
D. Strumberg (2011)
Intracellular imaging of nanoparticles: Is it an elemental mistake to believe what you see?
C. Brandenberger (2010)
Nanocarriers’ entry into the cell: relevance to drug delivery
H. Hillaireau (2009)
Membrane vesicles as conveyors of immune responses
C. Théry (2009)
Isolation of subcellular organelles and structures.
U. Michelsen (2009)
Screening and optimization of ligand conjugates for lysosomal targeting.
I. Meerovich (2011)
Uptake of exogenous DNA by rat liver: effect of cationic lipids.
R. Wattiaux (1995)
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
B. Shen (2012)
Endothelial nanoparticle binding kinetics are matrix and size dependent
Amber L Doiron (2011)
Safety assessment of nanomaterials: implications for nanomedicine.
Andreas M. Nystroem (2012)
When intracellular logistics fails - genetic defects in membrane trafficking
V. Olkkonen (2006)
Relapsed and Refractory Acute Myeloid Leukemia
S. Faderl (2014)
Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat.
S. Wedge (1991)
Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors.
D. Strumberg (2012)
Endocytosis of nanomedicines.
G. Sahay (2010)
Delivery of biologics to select organelles – the role of biologically active polymers
P. Dyer (2011)
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy
T. Beer (2010)
Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics.
R. Gaspar (2009)
Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.
S. Sigismund (2012)
Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates
P. Vasey (1999)
A status report on RNAi therapeutics
A. Vaishnaw (2010)
Protein toxins from plants and bacteria: Probes for intracellular transport and tools in medicine
K. Sandvig (2010)
Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats.
R. Duncan (1986)
Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys.
J. Yang (2012)
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes*
N. D. Sonawane (2003)
Imaging lysosomal enzyme activity in live cells using self-quenched substrates.
William H. Humphries (2012)
Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys.
M. Young (2007)
Paclitaxel poliglumex (XYOTAX; CT-2103): an intracellularly targeted taxane
J. Singer (2005)
Receptor-mediated gene delivery and expression in vivo.
G. Wu (1988)
CTb targeted non‐viral cDNA delivery enhances transgene expression in neurons
L. Barrett (2004)
Intracellular Fate of Polyethylenimine
S. Richardson (2000)
Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.
M. T. Tarragó-Trani (2007)
Interactions of basic polyelectrolytes with the red blood cell. II. Agglutination of red blood cells by polymeric bases.
A. Katchalsky (1959)
Optimization of Radioimmunotherapy of Solid Tumors: Biological Impediments and Their Modulation
Maneesh Jain (2007)
Aquaporins: a family of highly regulated multifunctional channels.
Charles Hachez (2010)
To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
M. Ogris (2011)
Polymer therapeutics-prospects for 21st century: the end of the beginning.
R. Duncan (2013)
Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release.
Dongbiao Shen (2012)
Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma
S. Telang (2011)
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
D. S. Wilson (2010)
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
J. Pollard (2012)
Silica and titanium dioxide nanoparticles cause pregnancy complications in mice.
K. Yamashita (2011)
Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease.
Z. Yang (2010)
Abstract B204: Development of ALN‐VSP: An RNAi therapeutic for liver malignancies
I. Toudjarska (2009)
Endocytosis and the recycling of plasma membrane
R. Steinman (1983)
High-speed imaging of Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells.
Peter Sandin (2012)
Chapter 8, Unit 8.1C
D. J. Gauthier (2003)
Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes.
You-Yeon Won (2009)
Autophagosome-Lysosome Fusion Depends on the pH in Acidic Compartments in CHO Cells
A. Kawai (2007)
Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.
S. Chia (2006)
More effective nanomedicines through particle design.
J. Wang (2011)
PRECEDENT: A randomized phase II trial comparing EC145 and pegylated liposomal doxorubicin (PLD) in combination, versus PLD alone, in subjects with platinum-resistant ovarian cancer.
R. W. Naumann (2011)
Metchnikoff and the phagocytosis theory
A. Tauber (2003)
Nanoparticles and cells: good companions and doomed partnerships.
D. Maysinger (2007)
Mechanisms of polarized membrane trafficking in neurons — Focusing in on endosomes
Z. Lasiecka (2011)
Synthetic gene transfer vectors II: back to the future.
Jean-Paul Behr (2012)
Endothelial transcytosis in health and disease
M. Simionescu (2008)
Proteomics of the lysosome.
T. Lübke (2009)
The endocytic matrix
G. Scita (2010)
Endocytic mechanisms for targeted drug delivery.
Lisa Bareford (2007)
Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.
T. Bhowmick (2012)
On the Question of Immunity in Infectious Diseases
I. Mechnikov (1974)
Coatomer and dimeric ADP ribosylation factor 1 promote distinct steps in membrane scission
R. Beck (2011)
How Ubiquitin Functions with ESCRTs
S. Shields (2011)
Antibody-drug conjugates: basic concepts, examples and future perspectives.
G. Casi (2012)
Transfer of PAMAM dendrimers across human placenta: prospects of its use as drug carrier during pregnancy.
A. R. Menjoge (2011)
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.
L. Seymour (2002)
First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.
E. Feldman (2011)
Functions of lysosomes.
C. de Duve (1966)
Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer
C. Langer (2008)
The use of fluorescence microscopy to define polymer localisation to the late endocytic compartments in cells that are targets for drug delivery.
S. Richardson (2008)
Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders
A. Fraldi (2010)
Subcellular targeting strategies for drug design and delivery
L. Rajendran (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
M. Davis (2010)
The B Subunit of Shiga Toxin Fused to a Tumor Antigen Elicits CTL and Targets Dendritic Cells to Allow MHC Class I-Restricted Presentation of Peptides Derived from Exogenous Antigens1
N. Haicheur (2000)
Regulation of apoptosis-associated lysosomal membrane permeabilization
A. Johansson (2009)
Individual organelle pH determinations of magnetically enriched endocytic organelles via laser-induced fluorescence detection.
C. Satori (2011)
Interactions of basic polyelectrolytes with the red blood cell. II. Agglutination of red blood cells by polymeric bases.
A. Karchalsky (1959)
The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity
B. Vingert (2006)
Lipid rafts: signaling and sorting platforms of cells and their roles in cancer
S. Staubach (2011)
Nanomedicine(s) under the microscope.
R. Duncan (2011)
Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells.
F. P. Seib (2007)
Imaging the cell entry of the anthrax oedema and lethal toxins with fluorescent protein chimeras
Irene Zornetta (2010)
Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts
W. Lim (2010)
Rabs and EHDs: alternate modes for traffic control.
J. Zhang (2012)
Poly(amidoamine) polymers: soluble linear amphiphilic drug-delivery systems for genes, proteins and oligonucleotides.
Marie W Pettit (2011)
Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal Doxorubicin.
R. Soloman (2008)
A phase I study of doxorubicin-loaded anti-EGFR immunoliposomes in patients with advanced solid tumors.
C. Mamot (2011)
Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.
R. Juliano (2012)
Patients with Advanced Solid Tumors
S. Chia (2011)
Virus Entry: Open Sesame
M. Marsh (2006)
The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents.
G. Sahay (2010)
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027.
P. Kaiser (2010)
Nanoparticles as a Novel Class of Autophagy Activators
Olga Zabirnyk (2007)
Regulated portals of entry into the cell
S. Conner (2003)
Degradation of side-chains ofN-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases
R. Duncan (1982)
Therapeutics-Promise and Challenges-Lessons learned through the NCI Alliance for Nanotechnology in Cancer
S. K. Libutti (2011)
Nucleic acid delivery: the missing pieces of the puzzle?
J. Nguyen (2012)
Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking.
A. Akinc (2002)
Polymer conjugates as anticancer nanomedicines
R. Duncan (2006)
Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer–doxorubicin
F. Philipp Seib (2006)
SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients.
N. Desai (2009)
Expression in Neurons
R. Gaspar (2004)
The ESCRT complexes
J. Hurley (2010)
RNAi-based therapeutics–current status, challenges and prospects
K. Tiemann (2009)
Interaction of basic polyamino acids with the red blood cell. I. Combination of polylysine with single cells.
A. Nevo (1955)
Nanotechnology-Based Cancer Therapeutics—Promise and Challenge—Lessons Learned Through the NCI Alliance for Nanotechnology in Cancer
D. Farrell (2010)
A membrane is born: origin of the autophagosomal compartment.
Militello Rd (2011)
Reducing Undesirable Hepatic Clearance of a Tumor-Targeted Vinca Alkaloid via Novel Saccharopeptidic Modifications
C. P. Leamon (2011)
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
N. Malik (2000)
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
A. Trouet (1982)
Studies on the mechanism of action of dextrin-phospholipase A2 and its suitability for use in combination therapy.
E. Ferguson (2010)
Commentary. Lysosomotropic agents.
C. de Duve (1974)
Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles
H. Kruth (2011)
Endosome‐disruptive peptides for improving cytosolic delivery of bioactive macromolecules
I. Nakase (2010)
Macrophages Recognize Size and Shape of Their Targets
N. Doshi (2010)
Polarized traffic towards the cell surface: how to find the route
Monica Carmosino (2009)
Chemical adaptor systems.
D. Shabat (2004)
Conjugation of anticancer drugs through endogenous monoclonal antibody cysteine residues.
R. Lyon (2012)
The dawning era of polymer therapeutics
R. Duncan (2003)
Leading a sheltered life: intracellular pathogens and maintenance of vacuolar compartments.
Y. Kumar (2009)
The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
E. Hurwitz (1975)
Phase I Clinical and Pharmacokinetic Study of PK1 [N-(Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents - Drug-Polymer
Biosci. Rep (1983)
Overview of the lipid formulations of amphotericin B.
B. Dupont (2002)
Bioresponsive polymers for the delivery of therapeutic nucleic acids.
Daniel Edinger (2011)
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
J. Lee (2012)
Histones and Basic Polyamino Acids Stimulate the Uptake of Albumin by Tumor Cells in Culture
H. J. Ryser (1965)
Evaluation of the biological properties of soluble chitosan and chitosan microspheres
B. Carreño-Gómez (1997)
Endocytosis at the nanoscale.
I. Cantón (2012)
The early endosome: a busy sorting station for proteins at the crossroads.
M. Jović (2010)
Caveolae: mining little caves for new cancer targets
Lucy A. Carver (2003)
The physics of cancer: the role of physical interactions and mechanical forces in metastasis
D. Wirtz (2011)
Trogocytosis of CD80 and CD86 by induced regulatory T cells
Peng Gu (2012)
Mycobacterium and Leishmania: stowaways in the endosomal network.
D. Russell (1995)
Regulation of Endocytic Sorting by ESCRT–DUB-Mediated Deubiquitination
M. H. Wright (2011)
Vectors: Implications for Lysosomal Trafficking
C. D. Blanchette (2002)
Imaging select mammalian organelles using fluorescent microscopy: application to drug delivery.
P. Dyer (2013)
Cationic lipids destabilize lysosomal membrane in vitro
R. Wattiaux (1997)
Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates*
M. Sutherland (2006)
This paper is referenced by
Novel synthesis of platinum complexes and their intracellular delivery to tumor cells by means of magnetic nanoparticles.
A. Quarta (2019)
Combretastatin A-4 Conjugated Antiangiogenic Micellar Drug Delivery Systems Using Dendron-Polymer Conjugates.
Burcu Sumer Bolu (2016)
Fluorescent Polymer Nanoparticles Based on Dyes: Seeking Brighter Tools for Bioimaging.
Andreas Reisch (2016)
Chemodynamics and bioavailability of metal ion complexes with nanoparticles in aqueous media
H. V. Leeuwen (2017)
Cellular uptake and intracellular trafficking of oligonucleotides.
R. Juliano (2015)
Bulk and Microfluidic-Assisted Preparation of Bioreducible Polyplexes for Gene Therapy
Filipe Coelho (2017)
Effect of the development of a cell barrier on nanoparticle uptake in endothelial cells.
Valentina Francia (2018)
Cell-Based Drug Delivery for Improving Antiretroviral Therapeutic Outcomes
J. McMillan (2014)
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution.
A. Vilella (2014)
Evaluation of diverse peptidyl motifs for cellular delivery of semiconductor quantum dots
Kelly Boeneman Gemmill (2013)
A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
J. Rappaport (2016)
Application of advances in endocytosis and membrane trafficking to drug delivery.
Yaping Ju (2020)
A Moment of Reflection: Sixty Years After the Nobel Prize for Hermann Staudinger
H. Ringsdorf (2013)
Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review.
Giulia Suarato (2016)
Insight into Mechanisms of Cellular Uptake of Lipid Nanoparticles and Intracellular Release of Small RNAs
Bo Yu (2014)
Exploiting endocytosis for nanomedicines.
A. Akinc (2013)
Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
Da Ma (2014)
NANOCARRIERS IN ORAL DELIVERY OF MACROMOLECULES: UPDATED INSIGHT
Saikh Mahammed Athar Alli (2013)
Dendrimer-based molecular imaging contrast agents
Z. Qiao (2015)
[Clathrin-independent endocytosis - role in disease processes and pharmaceutical aspects].
B. Konopska (2015)
ZnO-based nanocarriers for drug delivery application: From passive to smart strategies.
X. Huang (2017)
Combination of sequence‐defined oligoaminoamides with transferrin‐polycation conjugates for receptor‐targeted gene delivery
W. Zhang (2015)
Improved oral bioavailability and therapeutic efficacy of dabigatran etexilate via Soluplus-TPGS binary mixed micelles system
M. Hu (2017)
Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Ornchuma Naksuriya (2014)
Synthesis of pH-responsive chitosan nanocapsules for the controlled delivery of doxorubicin.
Chih-Kuang Chen (2014)
Strategies in the design of gold nanoparticles for intracellular targeting: opportunities and challenges.
Yamin Yang (2017)
Targeted drug delivery for cancer therapy: the other side of antibodies
M. Firer (2012)
Polypeptide-corticosteroid conjugates as a topical treatment approach to psoriasis.
Irene Dolz-Pérez (2019)
A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles
C. Vauthier (2019)
Multifunctional nanostructured biopolymeric materials for therapeutic applications
I. Armentano (2017)
Methods to follow intracellular trafficking of cell-penetrating peptides
Ly Pärnaste (2016)
GLP-1R–Targeting Magnetic Nanoparticles for Pancreatic Islet Imaging
Ping Wang (2014)See more